Form 8-K - Current report:
SEC Accession No. 0001193125-14-068418
Filing Date
2014-02-26
Accepted
2014-02-26 07:45:36
Documents
3
Period of Report
2014-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d685402d8k.htm 8-K 14733
2 EX-99.1 d685402dex991.htm EX-99.1 9390
3 GRAPHIC g685402ima1.jpg GRAPHIC 8446
  Complete submission text file 0001193125-14-068418.txt   37107
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 14642827
SIC: 2834 Pharmaceutical Preparations